Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
FOXO4-DRI enters senescent cells and competitively binds to p53 through its modified peptide sequence, displacing endogenous FOXO4 and freeing p53 to activate cell death pathways including BAX and PUMA
No reviews available
Mechanistically, its claimed effects track the biology of that TB4 motif: regulating actin dynamics, driving cell migration, and supporting new vessel growth and tissue repair
Most of that nausea is mild to moderate and concentrated in the first few weeks of each dose escalation
The short answer: there is promising but limited evidence
Each peptide product category is subject to standardized verification processes intended to reduce variability in product integrity and maintain alignment with established laboratory handling requirements
US$ 25.65
US$ 23.28
US$ 28.59
US$ 22.00
